{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:33:47Z","timestamp":1794285227067,"version":"4.9.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":47,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.032","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T13:15:26Z","timestamp":1496409326000},"page":"3780-3788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Naif Khalaf","family":"Alharbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Padron-Regalado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9248-9365","authenticated-orcid":false,"given":"Craig P.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kupke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Grehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Warimwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2017.05.032_b0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.032_b0010","unstructured":"World Health Organisation. Middle East respiratory syndrome coronavirus (MERS-CoV) 2016. Available from: http:\/\/www.who.int\/emergencies\/mers-cov\/en\/ [accessed 20.02.2017]."},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.032_b0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/aje\/kwv452","article-title":"Estimating the severity and subclinical burden of Middle East respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia","volume":"183","author":"Lessler","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.032_b0020","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3201\/eid2112.151132","article-title":"Asymptomatic MERS-CoV infection in humans possibly linked to infected dromedaries imported from Oman to United Arab Emirates, May 2015","volume":"21","author":"Al Hammadi","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.032_b0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1408636","article-title":"2014 MERS-CoV outbreak in Jeddah\u2013a link to health care facilities","volume":"372","author":"Oboho","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.032_b0030","doi-asserted-by":"crossref","unstructured":"Who Mers-Cov Research G. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr 2013;5.","DOI":"10.1371\/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.032_b0035","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMc1308698","article-title":"Middle East respiratory syndrome coronavirus infections in health care workers","volume":"369","author":"Memish","year":"2013","journal-title":"New Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.032_b0040","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3201\/eid2012.141026","article-title":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983\u20131997","volume":"20","author":"Muller","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.032_b0045","doi-asserted-by":"crossref","unstructured":"Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2013;18(36): pii=20574.","DOI":"10.2807\/1560-7917.ES2013.18.36.20574"},{"issue":"23","key":"10.1016\/j.vaccine.2017.05.032_b0050","article-title":"Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity","volume":"19","author":"Hemida","year":"2014","journal-title":"Euro Surveillance: Bull Eur sur les maladies transmissibles = Eur Commun Dis Bull"},{"issue":"37","key":"10.1016\/j.vaccine.2017.05.032_b0055","article-title":"Presence of antibodies but no evidence for circulation of MERS-CoV in dromedaries on the Canary Islands, 2015","volume":"20","author":"Gutierrez","year":"2015","journal-title":"Euro Surveillance: Bull Eur sur les maladies transmissibles = Eur Commun Dis Bull"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.032_b0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/emi.2016.130","article-title":"Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt","volume":"6","author":"Ali","year":"2017","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.032_b0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/vbz.2016.2062","article-title":"High prevalence of Middle East respiratory coronavirus in young dromedary camels in Jordan","volume":"17","author":"van Doremalen","year":"2017","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.032_b0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3201\/eid2201.151340","article-title":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014","volume":"22","author":"Alraddadi","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.032_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/zph.12171","article-title":"Human-dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus infection","volume":"63","author":"Gossner","year":"2016","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2017.05.032_b0080","first-page":"88","article-title":"MERS-CoV at the animal-human interface: inputs on exposure pathways from an expert-opinion elicitation","volume":"3","author":"Funk","year":"2016","journal-title":"Front Veterin Sci"},{"issue":"50","key":"10.1016\/j.vaccine.2017.05.032_b0085","doi-asserted-by":"crossref","first-page":"20662","DOI":"10.2807\/1560-7917.ES2013.18.50.20662","article-title":"Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013","volume":"18","author":"Reusken","year":"2013","journal-title":"Euro Surveillance: Bull Eur sur les maladies transmissibles = Eur Commun Dis Bull"},{"issue":"50","key":"10.1016\/j.vaccine.2017.05.032_b0090","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.2807\/1560-7917.ES2013.18.50.20659","article-title":"Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013","volume":"18","author":"Hemida","year":"2013","journal-title":"Euro Surveillance: Bull Eur sur les maladies transmissibles = Eur Commun Dis Bull"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.032_b0095","doi-asserted-by":"crossref","first-page":"e00884","DOI":"10.1128\/mBio.00884-14","article-title":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia","volume":"5","author":"Alagaili","year":"2014","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.032_b0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1473-3099(13)70164-6","article-title":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study","volume":"13","author":"Reusken","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.032_b0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3201\/eid2302.161239","article-title":"Livestock susceptibility to Infection with Middle East respiratory syndrome coronavirus","volume":"23","author":"Vergara-Alert","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.032_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/v8080230","article-title":"Inoculation of goats, sheep, and horses with MERS-CoV does not result in productive viral shedding","volume":"8","author":"Adney","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.05.032_b0115","article-title":"Vaccines against Middle East respiratory syndrome coronavirus for humans and camels","author":"Alharbi","year":"2016","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.032_b0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.032_b0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model","volume":"201","author":"Tao","year":"2005","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.032_b0130","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PloS one"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.032_b0135","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1586\/14760584.2013.845531","article-title":"Clinical applications of attenuated MVA poxvirus strain","volume":"12","author":"Gomez","year":"2013","journal-title":"Exp Rev Vacc"},{"issue":"39","key":"10.1016\/j.vaccine.2017.05.032_b0140","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of modified vaccinia virus Ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.05.032_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jviromet.2008.08.011","article-title":"Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice","volume":"154","author":"Luo","year":"2008","journal-title":"J Virol Meth"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.032_b0150","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4161\/hv.26009","article-title":"Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1)","volume":"9","author":"Wallace","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.032_b0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vaccine.2015.11.028","article-title":"Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter","volume":"34","author":"Alharbi","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.032_b0160","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee adenovirus vaccine provides multispecies protection against rift valley fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.032_b0165","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther: J Am Soc Gene Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.032_b0170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/bit.24342","article-title":"Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors","volume":"109","author":"Cottingham","year":"2012","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.032_b0175","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/JVI.02568-07","article-title":"Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A","volume":"82","author":"Sridhar","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.032_b0180","doi-asserted-by":"crossref","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA)","volume":"3","author":"Cottingham","year":"2008","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2017.05.032_b0185","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant Modified Vaccinia virus Ankara (MVA) delivering Middle East Respiratory Syndrome coronavirus spike glycoprotein","author":"Volz","year":"2015","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2017.05.032_b0190","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/JVI.00427-06","article-title":"Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice","volume":"80","author":"Tscharke","year":"2006","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.032_b0195","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nm.1850","article-title":"Effective induction of high-titer antibodies by viral vector vaccines","volume":"14","author":"Draper","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.05.032_b0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.mex.2015.09.003","article-title":"An optimised method for the production of MERS-CoV spike expressing viral pseudotypes","volume":"2","author":"Grehan","year":"2015","journal-title":"MethodsX."},{"issue":"21","key":"10.1016\/j.vaccine.2017.05.032_b0205","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J Virol"},{"issue":"301","key":"10.1016\/j.vaccine.2017.05.032_b0210","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.032_b0215","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2017.05.032_b0220","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"issue":"6268","key":"10.1016\/j.vaccine.2017.05.032_b0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.05.032_b0230","unstructured":"Pellerin C. Army Scientists Begin First MERS Vaccine Clinical Trial. DoD News, Defense Media Activity; 2016."},{"key":"10.1016\/j.vaccine.2017.05.032_b0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-10-349","article-title":"Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice","volume":"10","author":"Warimwe","year":"2013","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.vaccine.2017.05.032_b0240","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1038\/emi.2016.114","article-title":"Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China","volume":"5","author":"Wang","year":"2016","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.vaccine.2017.05.032_b0245","doi-asserted-by":"crossref","first-page":"25359","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.032_b0250","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea","volume":"21","author":"Park","year":"2015","journal-title":". Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.032_b0255","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/cid\/civ951","article-title":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection","volume":"62","author":"Corman","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:01:47Z","timestamp":1750287707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":51,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306564"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}